这篇文章不错，转发给_老虎社区_美港股上老虎

这篇文章不错，转发给大家看看

Star Sports Medicine Nets HK$758 Million Ahead of Hong Kong Trading Debut<blockquote>Star Sports Medicine在香港上市前净赚7.58亿港元</blockquote>

Star Sports Medicine (HKG:1609) raised HK$758.4 million in net proceeds from its initial public offering in Hong Kong.The offer price was set at HK$98.50 per H-share, according to a Monday filing with

Star Sports Medicine Nets HK$758 Million Ahead of Hong Kong Trading Debut<blockquote>Star Sports Medicine在香港上市前净赚7.58亿港元</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":560804930344632,"tweetId":"560804930344632","gmtCreate":1777947027888,"gmtModify":1777947030056,"author":{"id":3537240691950598,"idStr":"3537240691950598","authorId":3537240691950598,"authorIdStr":"3537240691950598","name":"momo_7","avatar":"https://static.tigerbbs.com/7f1d227ba61bf034c6807442fc2572e6","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body>这篇文章不错，转发给大家看看</body></html>","htmlText":"<html><head></head><body>这篇文章不错，转发给大家看看</body></html>","text":"这篇文章不错，转发给大家看看","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/560804930344632","repostId":2633996446,"repostType":2,"repost":{"id":"2633996446","kind":"highlight","weMediaInfo":{"introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"media_name":"MT Newswires Live","id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"pubTimestamp":1777932327,"share":"https://www.laohu8.com/m/news/2633996446?lang=zh_CN&edition=full","pubTime":"2026-05-05 06:05","market":"nz","language":"en","title":"Star Sports Medicine Nets HK$758 Million Ahead of Hong Kong Trading Debut<blockquote>Star Sports Medicine在香港上市前净赚7.58亿港元</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=2633996446","media":"MT Newswires Live","summary":"Star Sports Medicine (HKG:1609) raised HK$758.4 million in net proceeds from its initial public offering in Hong Kong.The offer price was set at HK$98.50 per H-share, according to a Monday filing with","content":"<p><html><body> <a href=\"https://laohu8.com/S/SGU\">Star</a> Sports Medicine (HKG:1609) raised HK$758.4 million in net proceeds from its initial public offering in Hong Kong.</p><p><blockquote><html><body><a href=\"https://laohu8.com/S/SGU\">星</a>Sports Medicine(HKG：1609)于香港首次公开发售募集所得款项净额758.4百万港元。</body></html></blockquote></p><p>The offer price was set at HK$98.50 per H-share, according to a Monday filing with the Hong Kong Stock Exchange.</p><p><blockquote>根据周一提交给香港联交所的文件，发售价定为每股H股98.50港元。</blockquote></p><p>The China-based medical device company offered 8.4 million H-shares in the global offering.</p><p><blockquote>这家总部位于中国的医疗器械公司在全球发售中发行了840万股H股。</blockquote></p><p>The Hong Kong public offer was 7,823.13 times subscribed, with a final allocation of 842,200 shares, representing 10% of the total offering.</p><p><blockquote>香港公开发售获7823.13倍认购，最终获配84.22万股，占发售总额10%。</blockquote></p><p>The international offering was 10.41 times subscribed, with a final allocation of 7.6 million shares, or 90% of the total offering.</p><p><blockquote>国际发售获10.41倍认购，最终获配760万股，占发售总量90%。</blockquote></p><p>Cornerstone investors, including JSC International Investment Fund SPC, OAP IV (HK) Limited, and Greater Bay Area Development Fund Management, were allocated about 2.9 million shares in the international tranche, according to the filing.</p><p><blockquote>文件显示，包括JSC国际投资基金SPC、OAP IV(HK)Limited和大湾区发展基金管理公司在内的基石投资者在国际部分中获得了约290万股股票。</blockquote></p><p>Star Sports Medicine is scheduled to debut on the Hong Kong bourse on Tuesday, May 5.</p><p><blockquote>Star Sports Medicine计划于5月5日（星期二）在香港证券交易所上市。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","source":"mtnewswires_news","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Star Sports Medicine Nets HK$758 Million Ahead of Hong Kong Trading Debut<blockquote>Star Sports Medicine在香港上市前净赚7.58亿港元</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStar Sports Medicine Nets HK$758 Million Ahead of Hong Kong Trading Debut<blockquote>Star Sports Medicine在香港上市前净赚7.58亿港元</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2026-05-05 06:05</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p><html><body> <a href=\"https://laohu8.com/S/SGU\">Star</a> Sports Medicine (HKG:1609) raised HK$758.4 million in net proceeds from its initial public offering in Hong Kong.</p><p><blockquote><html><body><a href=\"https://laohu8.com/S/SGU\">星</a>Sports Medicine(HKG：1609)于香港首次公开发售募集所得款项净额758.4百万港元。</body></html></blockquote></p><p>The offer price was set at HK$98.50 per H-share, according to a Monday filing with the Hong Kong Stock Exchange.</p><p><blockquote>根据周一提交给香港联交所的文件，发售价定为每股H股98.50港元。</blockquote></p><p>The China-based medical device company offered 8.4 million H-shares in the global offering.</p><p><blockquote>这家总部位于中国的医疗器械公司在全球发售中发行了840万股H股。</blockquote></p><p>The Hong Kong public offer was 7,823.13 times subscribed, with a final allocation of 842,200 shares, representing 10% of the total offering.</p><p><blockquote>香港公开发售获7823.13倍认购，最终获配84.22万股，占发售总额10%。</blockquote></p><p>The international offering was 10.41 times subscribed, with a final allocation of 7.6 million shares, or 90% of the total offering.</p><p><blockquote>国际发售获10.41倍认购，最终获配760万股，占发售总量90%。</blockquote></p><p>Cornerstone investors, including JSC International Investment Fund SPC, OAP IV (HK) Limited, and Greater Bay Area Development Fund Management, were allocated about 2.9 million shares in the international tranche, according to the filing.</p><p><blockquote>文件显示，包括JSC国际投资基金SPC、OAP IV(HK)Limited和大湾区发展基金管理公司在内的基石投资者在国际部分中获得了约290万股股票。</blockquote></p><p>Star Sports Medicine is scheduled to debut on the Hong Kong bourse on Tuesday, May 5.</p><p><blockquote>Star Sports Medicine计划于5月5日（星期二）在香港证券交易所上市。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1148":"建筑与工程","01609":"天星医疗"},"source_url":"https://www.mtnewswires.com/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2633996446","content_text":"Star Sports Medicine (HKG:1609) raised HK$758.4 million in net proceeds from its initial public offering in Hong Kong.The offer price was set at HK$98.50 per H-share, according to a Monday filing with the Hong Kong Stock Exchange.The China-based medical device company offered 8.4 million H-shares in the global offering.The Hong Kong public offer was 7,823.13 times subscribed, with a final allocation of 842,200 shares, representing 10% of the total offering.The international offering was 10.41 times subscribed, with a final allocation of 7.6 million shares, or 90% of the total offering.Cornerstone investors, including JSC International Investment Fund SPC, OAP IV (HK) Limited, and Greater Bay Area Development Fund Management, were allocated about 2.9 million shares in the international tranche, according to the filing.Star Sports Medicine is scheduled to debut on the Hong Kong bourse on Tuesday, May 5.","news_type":1,"symbols_score_info":{"01609":0.9}},"isVote":1,"tweetType":1,"viewCount":16,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":27,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}